Enquête en ligne canadienne relative aux perspectives du personnel infirmier en oncologie sur la gestion de la douleur aiguë liée au cancer (DAC)

Margaret I. Fitch, Alison McAndrew, Stephanie Burlein-Hall

Abstract


Cet article vise à explorer les perceptions du personnel infirmier en oncologie du Canada relativement à la gestion de la douleur aiguë liée au cancer (DAC). Un questionnaire en ligne a été distribué à 668 infirmières en oncologie de l’ensemble du Canada, et 201 d’entre elles l’ont rempli. Davantage d’infirmières ont rapporté que les patients recevaient de l’hydromorphone (99,5 %), de la morphine (97,0 %), de la codéine (88,1 %) ou de l’oxycodone (88,1 %) pour leur DAC plutôt que des préparations à base de fentanyl (64,7 %). Les problèmes liés à l’administration d’opioïdes signalés par les infirmières comprenaient notamment la lenteur d’apparition de leur effet (35,7 %), la difficulté à les avaler (16,6 %), le besoin de faire appel à un aidant (13,2 %), les lésions buccales (12,6 %) et la sécheresse de la bouche (11,5 %). Quoique la plupart des infirmières abordaient la gestion de la DAC avec leurs patients, la grande majorité (72,2 %) de ces derniers n’étaient pas très satisfaits des modalités de traitement actuelles. Un dialogue efficace avec les patients et l’accès à des outils/ressources pédagogiques pourraient contribuer à l’optimisation de la thérapie et à rehausser l’observation des recommandations en matière d’ordonnances contre la DAC.


Full Text:

PDF

References


Canadian Institute for Health Information (CIHI). (2010). Canada’s

nursing workforce grows 9% in five years. Retrieved from

http://www.cihi.ca/cihi-ext-portal/internet/en/document/

spending+and+health+workforce/workforce/nurses/

release_09dec2010

The Canadian Pain Society (CPS) and the Canadian Pain Coalition

(CPC) Call to Action: The need for a National Pain Strategy for

Canada (NPSC). (2011, December 15). CPS National Task Force

on Service Delivery (first draft), July 2010. Retrieved from http://

www.canadianpainsummit2012.ca/media/11445/final%20

nat%20pain%20strategy%20for%20can%20121511%20eng.pdf.

Presented in Ottawa on April 24, 2012 at the Canadian Pain

Summit.

Cancer Care Ontario (CCO). (2008). Cancer-related Pain Management:

A Report of Evidence-Based Recommendations to Guide Practice.

Evidence-Based Series #16-2. Report Date: March 17, 2008.

Retrieved from https://www.cancercare.on.ca/common/pages/

UserFile.aspx?files=44127

CANO/ACIO (2011). CANO/ACIO Position Statement on the Nursing

Care of Persons Living with Cancer Pain. Retrieved from

http://www.cano-acio.ca/~ASSETS/DOCUMENT/About%20Us/

CANO%20Position%20statement%20on%20Pain.pdf

Davies, A., Zeppetella, G., Andersen, S., Damkier, A., Vejlgaard, T.,

Nauck, F., … Buchanan, A. (2011). Multi-centre European study

of breakthrough cancer pain: pain characteristics and patient

perceptions of current and potential management strategies.

[Multicenter Study Research Support, Non-U.S. Gov’t]. Eur J Pain,

(7), 756–763. doi:10.1016/j.ejpain.2010.12.004

Davis, M.P. (2011). Fentanyl for breakthrough pain: A systematic

review. [Review]. Expert Rev Neurother, 11(8), 1197–1216.

doi:10.1586/ern.11.63

Dobrow, M.J., Orchard, M.C., Golden, B., Holowaty, E., Paszat, L.,

Brown, A.D., & Sullivan, T. (2008). Response audit of an Internet

survey of health care providers and administrators: Implications

for determination of response rates. [Research Support, Non-U.S.

Gov’t]. J Med Internet Res, 10(4), e30. doi:10.2196/jmir.1090

Donner, B., & Zenz, M. (1995). Transdermal fentanyl: A new step

on the therapeutic ladder. [Clinical Trial Multicenter Study].

Anticancer Drugs, 6 Suppl 3, 39–43.

Elcigil, A., Maltepe, H., Esrefgil, G., & Mutafoglu, K. (2011). Nurses’

perceived barriers to assessment and management of pain in a

university hospital. J Pediatr Hematol Oncol, 33(Suppl. 1), S33–

doi:10.1097/MPH.0b013e3182121bef

European Oncology Nursing Society (2011). Backgrounder:

European Survey of Oncology Nurse Breakthrough Cancer Pain

Practices. Retrieved from http://www.cancernurse.eu/research/

breakthroughcancerpain.html

European Oncology Nursing Society (EONS). (2012). Breakthrough

Cancer Pain Initiative. Retrieved from http://www.cancernurse.

eu/research/breakthroughcancerpain.html

Glare, P., Aggarwal, G., & Clark, K. (2004). Ongoing controversies

in the pharmacological management of cancer pain. [Review].

Intern Med J, 34(1–2), 45–49.

Green, E., Zwaal, C., Beals, C., Fitzgerald, B., Harle, I., Jones, J., …

Wiernikowski, J. (2010). Cancer-related pain management: A

report of evidence-based recommendations to guide practice.

[Research Support, Non-U.S. Gov’t]. Clin J Pain, 26(6), 449–462.

doi:10.1097/AJP.0b013e3181dacd62

Hanks, G.W., Conno, F., Cherny, N., Hanna, M., Kalso, E., McQuay,

H.J., … Ventafridda, V. (2001). Morphine and alternative

opioids in cancer pain: The EAPC recommendations. [Guideline

Practice Guideline]. Br J Cancer, 84(5), 587–593. doi:10.1054/

bjoc.2001.1680

Haugen, D.F., Hjermstad, M.J., Hagen, N., Caraceni, A., & Kaasa, S.

(2010). Assessment and classification of cancer breakthrough

pain: A systematic literature review. [Research Support, Non-

U.S. Gov’t Review]. Pain, 149(3), 476–482. doi:10.1016/j.

pain.2010.02.035

Jacobsen, R., Moldrup, C., & Christrup, L. (2008). Clinical rationale

for administering fentanyl to cancer pain patients: Two Delphi

surveys of pain management experts in Denmark. [Research

Support, Non-U.S. Gov’t]. J Opioid Manag, 4(6), 383–391.

Jacobsen, R., Moldrup, C., & Christrup, L. (2009). Danish pain

specialists’ rationales behind the choice of fentanyl transdermal

patches and oral transmucosal systems—a Delphi study.

[Research Support, Non-U.S. Gov’t]. Pain Med, 10(8), 1442–1451.

doi:10.1111/j.1526-4637.2009.00724.x

McCaffery M. (1968). Nursing practice theories related to cognition,

bodily pain, and man-environment interactions. Los Angeles:

UCLA Students Store.

Mercadante, S. (2011). Managing breakthrough pain. [Review].

Curr Pain Headache Rep, 15(4), 244–249. doi:10.1007/

s11916-011-0191-5

Mercadante, S., Radbruch, L., Caraceni, A., Cherny, N., Kaasa,

S., Nauck, F., … De Conno, F. (2002). Episodic (breakthrough)

pain: Consensus conference of an expert working group of

the European Association for Palliative Care. [Consensus

Development Conference Review]. Cancer, 94(3), 832–839.

Mercadante, S., Villari, P., & Casuccio, A. (2011). An Italian survey

on the attitudes in treating breakthrough cancer pain in

hospice. Support Care Cancer, 19(7), 979–983. doi:10.1007/

s00520-010-0919-5

Morere, J.F., Poulain, P., Filbet, M., Krakowski, I., Serrie, A., Delorme,

C., Ammar, D., Scotte, F., & Grange, V. (2011). A national

prospective survey of breakthrough cancer pain characteristics

and treatments in France 10 years after the preliminary study

(ASCO 2000). Journal of Clinical Oncology, 2011 ASCO Annual

Meeting Proceedings (Post-Meeting Edition) Vol 29(No 15, Suppl.).

(May 20 Supplement)), e19661.

Portenoy, R.K., & Hagen, N.A. (1990). Breakthrough pain: Definition,

prevalence and characteristics. [Research Support, Non-U.S.

Gov’t]. Pain, 41(3), 273–281.

Portenoy, R.K., Payne, D., & Jacobsen, P. (1999). Breakthrough pain:

Characteristics and impact in patients with cancer pain. Pain,

(1-2), 129–134.

World Health Organization. (1996). Cancer Pain Relief, 2nd edition.

WHO: Geneva.

Zeppetella, G. (2008). Opioids for cancer breakthrough pain: A pilot

study reporting patient assessment of time to meaningful pain

relief. J Pain Symptom Manage, 35(5), 563–567. doi:10.1016/j.

jpainsymman.2007.06.012

Zeppetella, G. (2011a). Breakthrough pain in cancer patients.

[Review]. Clin Oncol (R Coll Radiol), 23(6), 393–398. doi:10.1016/j.

clon.2010.12.002

Zeppetella, G. (2011b). Opioids for the management of breakthrough

cancer pain in adults: A systematic review undertaken as part of

an EPCRC opioid guidelines project. Palliat Med, 25(5), 516–524.

doi:10.1177/0269216310385601

Zeppetella, G., O’Doherty, C.A., & Collins, S. (2000). Prevalence and

characteristics of breakthrough pain in cancer patients admitted

to a hospice. [Clinical Trial]. J Pain Symptom Manage, 20(2),

–92.

Zeppetella, G., & Ribeiro, M.D. (2003). Pharmacotherapy of cancerrelated

episodic pain. [Review]. Expert Opin Pharmacother, 4(4),

–502. doi:10.1517/14656566.4.4.493


Refbacks

  • There are currently no refbacks.


Bookmark and Share